-
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Valk, A. M., Koers, J., Derksen, N. I. L., Hogenboom, L., van Kempen, Z., Killestein, J., Rutgers, A., Heeringa, P., Horváth, B., Kuijpers, T. W., van Ham, S. M., Brinke, A. T., van der Woude, D., Toes, R. E. M., Bos, N. A., Rispens, T., Bos, A., Kummer, L. Y., Wieske, L. & Koning, M. & 5 others, , 1 Dec 2025, In: Scientific reports. 15, 1, 14770.Research output: Contribution to journal › Article* › Academic › peer-review
-
B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses
T2B Consortium, 1 Sept 2023, In: Life science alliance. 6, 9, e202302214.Research output: Contribution to journal › Article* › Academic › peer-review
-
Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets
T2B Consortium, Sept 2023, In: Journal of allergy and clinical immunology. 152, 3, p. 689-699.e6Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
